NCT07231367

Brief Summary

This study evaluates the effect of daily consumption of sunflower seeds on blood cholesterol levels in adult participants. Participants were randomly assigned to consume a specified amount of sunflower seeds for a defined period, and their blood cholesterol and lipid profile were measured before and after the intervention. The study aims to determine whether sunflower seeds can contribute to improving cardiovascular health by lowering cholesterol. Adult men and women meeting the eligibility criteria were included in the study. The findings may help inform dietary recommendations for managing cholesterol and promoting heart health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 5, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2023

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

November 13, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 17, 2025

Completed
Last Updated

November 17, 2025

Status Verified

November 1, 2025

Enrollment Period

2 months

First QC Date

November 13, 2025

Last Update Submit

November 13, 2025

Conditions

Keywords

Sunflower seedsHypercholesterolemiaCholesterolPhytochemicals

Outcome Measures

Primary Outcomes (1)

  • Change in Total Cholesterol

    Total serum cholesterol measured using standard enzymatic methods at baseline and at the end of the 45 days sunflower seed supplementation period.

    Baseline and 45 days after intervention

Secondary Outcomes (1)

  • LDL Cholesterol

    Baseline and 45 days after intervention

Study Arms (2)

Control

NO INTERVENTION

Participants continued their usual diet without consuming sunflower seeds. Blood cholesterol and lipid profiles were measured at baseline and at the end of the study period.

Diseased Group

EXPERIMENTAL

Participants consumed a defined daily portion of sunflower seeds for the duration of the study. Blood samples were collected at baseline and after the intervention to measure total cholesterol, LDL-C, HDL-C, triglycerides, and other lipid parameters. Dietary intake and adherence to the intervention were monitored throughout the study period

Dietary Supplement: Sunflower Seed Supplementation

Interventions

Participants consumed sunflower seeds daily for 45 days

Diseased Group

Eligibility Criteria

Age40 Years - 50 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Participants included males aged between 40 and 50 years, with serum cholesterol levels exceeding 200 mg/dL, and shared the same socioeconomic status.

You may not qualify if:

  • The participants were excluded based on different physiological factors, such as active smokers, alcoholics, chronic disease patients, people having extremely low or high BMI, people suffering from psychological disorders or familial hypercholesterolemia, people who belong to a high-income group, and people having doubts or confusion while following instructions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Agriculture, Faisalabad

Faisalābad, Punjab Province, 38000, Pakistan

Location

MeSH Terms

Conditions

Hypercholesterolemia

Condition Hierarchy (Ancestors)

HyperlipidemiasDyslipidemiasLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

November 13, 2025

First Posted

November 17, 2025

Study Start

July 5, 2023

Primary Completion

August 20, 2023

Study Completion

August 20, 2023

Last Updated

November 17, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

The study was completed prior to an IPD sharing plan, and participant consent did not include sharing of individual-level data.

Locations